• DNDi-20_Logo_No-Tagline_EN_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia/India
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi-20_Logo_No-Tagline_EN_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia/India
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events > A Decade of R&D for Neglected Diseases in Africa > Page 4

A Decade of R&D for Neglected Diseases in Africa

4-5 June 2013

Nairobi, Kenya

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print
  • Speech
    • Overview
    • Programme
    • Keynote Address
    • Speech
    • Presentations
    • Press releases
    • Press Clippings
    • Videos
    • Gallery
    • DNDi in Africa

Speech

SPEECH BY THE KENYA CABINET SECRETARY FOR HEALTH HON. JAMES MACHARIA, DURING THE OFFICIAL OPENING CEREMONY

Hon. Governor of Nairobi, Dr. Evans Kidero,
Hon. Ministers,
Your Excellencies the Ambassadors,
Distinguished delegates,
Other Invited Guests,
Ladies and Gentlemen,

I am truly delighted to be here to open this forum on A Decade of R&D for Neglected Diseases in Africa: Endemic Country Research and Development for Patient Access.

May I take this early opportunity to welcome all of you to this important event. Indeed forums of this nature are an opportunity for each one of us to reflect on achievements of DNDi and many other important initiatives after a decade of engagement. These significant achievements will enhance our future plans for the next decade towards the realization of “Connect to fight neglect”.

Distinguished guests, I wish recognise the significant contributions by KEMRI, Drugs for Neglected Diseases and other partners in ensuring issues that affect the health of our people are addressed. Your engagement and achievements for research and development for the most neglected diseases serves as a clarion call to all of us in Africa’s health and research sector.

As most of you may know in May of this year, the 66th World Health Assembly adopted a landmark resolution on neglected tropical diseases to ensure country ownership of prevention, control, elimination and eradication programmes for these diseases which are both the result and the cause of poverty in Africa.

This NTD resolution gives us all the impetus and the collective responsibility for universal access to interventions and for mobilizing the resources, policies, and interventions to reach the targets of the WHO Roadmap for neglected tropical diseases. Today we must begin putting this strategy into action.

Ladies and gentlemen, today major achievements have been documented in the field of NTDs, but we must remember that the road ahead is still long – many patients are still in need of being diagnosed and treated with good quality and adapted drugs. I wish to assure you of our commitment as the Government in supporting this initiative. Our appreciation to all the collaborators, we highly applaud our association and partnership. We acknowledge the enormous contributions of the various partners and collaborators to our health research development; together we will ensure better health not only to the Kenyan people but for Africans and the world at large.

As you are aware many neglected diseases with high prevalence in Africa either occur almost exclusively on the continent – for example, sleeping sickness or river blindness – or affect the continent disproportionately, such as HIV/AIDS, malaria, kala azar or tuberculosis. These infectious diseases form a large portion of Africa’s total disease burden.

The economic impact is difficult to assess. But, we know that Africa is losing billions of dollars each year as a result of these diseases, keeping millions in a vicious circle of disease and poverty.

Despite the terrible impact these diseases have on Africa’s economic development and welfare, they have been seriously under-researched.

During your deliberations today I hope that you will take note of the real benefits of bringing new health tools for public health, and of the fact that these benefits cannot happen in “Silo operations”. The past decade has seen innovation in partnerships, combining North-South and South-South collaborations in ways that have allowed for capacity to be built to conduct clinical research for Africa, in Africa, and by Africa. Innovative Partnerships and strong alliances are one of the main lessons learned from the last decade!

Today, Ladies and Gentlemen, we can say that even in some of the most remote areas of our continent, international standard clinical trials are being conducted.

If we look at the scientific publications generated by the research that is going on in Africa we see that, despite the growing capacity to conduct research, the actual impact in terms of scientific publication outputs from Africa needs to be enhanced so as to reach the levels of outputs like the developed countries. My challenge to you today is not just to increase the outputs in publications but also ensure uptake of research findings for policy.

As public health professionals, we have the basic knowledge of these diseases. As the African scientific community, we need to strive to build the scientific excellence to take ownership of research for health. I am proud of the achievements of KEMRI and other African research institutions and encourage their work in achieving this goal.

Distinguished guests, health research is also about how our health systems operationalize and enhance the advances made in clinical management of neglected diseases.

I believe Africa is ready to take a step in this field, to develop and implement integrated strategies for neglected diseases. By this we mean strategies to tackle several diseases together in comprehensive programmes. These policies can lead to less duplication of efforts and resources – in short, cause less economic burden on our health systems and address the health needs of our populations. African countries have begun to take this very important first step, Kenya is one of several.

But even with such integrated strategies, and the political will required to propel them – in addition to the resources required from them – we must not forget that the right tools for elimination are necessary to really see the elimination of many of these diseases.

We now have the capacity to test diagnostics, vaccines, and drugs. But we need to ensure that the resources required to get them through the research and development process will be forthcoming and sustained. We also need to ensure that we are working together as African countries, through collaboration across the various sectors and borders we must maximise on these resources. The current reflections and efforts to harmonize regulatory processes are promising and will also be vital to ensuring that the fruits of research and development translate rapidly into safe and effective treatments.

Distinguished guests, I am convinced and have no doubt that “Connect to Fight Neglect” is achievable. I wish you all very fruitful discussions and look forward to receiving your recommendations.

It is now my pleasure to declare this auspicious occasion marking DNDi’s 10 Year anniversary celebrations OFFICIALLY OPEN.

Karibuni!

Pages: Page 1, Page 2, Page 3, Page 4, Page 5, Page 6, Page 7, Page 8, Page 9, Page 10

Other events

Loading...
6 February 2023, 5 PM Madrid

Madrid, Spain and online

La Salud Global y las Enfermedades Tropicales Desatendidas en su día mundial

30 January 2023, 5-8 PM Hamburg

Hamburg, Germany

World NTD Day 2023: Snack & Talk about NTDs

29 January 2023

Referral Hospital, Baniapur, Saran, Bihar

Honouring frontline heroes of NTDs

26 January 2023

Santa Cruz de Tenerife, Spain

Jornada enfermedades tropicales desatendidas, cooperación en salud y farmacia solidaria

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo